webinar register page

Webinar Title: Targeted Treatment Strategies for Advanced Cholangiocarcinoma: Results of Promising Trials
Dr. Lipika Goyal provides an overview of the actionable targets in cholangiocarcinoma, including data from the FOENIX-CCA2 study, for the use of futibatinib, an irreversible pan-FGFR inhibitor, in advanced cholangiocarcinoma. Dr. Volker Wacheck (Taiho Oncology) also provides an overview of the Expanded Access Study (NCT04507503) of futibatinib in cholangiocarcinoma

Sep 29, 2022 02:00 PM in Mountain Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Cholangiocarcinoma Foundation.